第三代定序市場：按技術、組件、應用、最終用戶和地區分類。

Third Generation Sequencing Market, By Type of Technology, By Component, By Application, By End-User, By Geography

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，第三代定序市場在2026年的價值為10.691億美元，預計到2033年將達到41.31億美元。預計從2026年到2033年，其複合年成長率將達到21.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1,069,100,000 美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	21.30%	2033年市場規模預測：	41.31億美元

第三代定序（也稱為長讀長定序）是一種DNA定序技術。第三代定序透過在單分子層次上讀取核苷酸序列，能夠產生比現有方法長得多的讀長。它能夠產生比第二代定序（也稱為第三代定序）更長的讀長。此外，第三代定序正逐漸成為cDNA定序領域的「黃金標準」技術。

市場動態

慢性病和感染疾病的日益普及、臨床診斷應用的不斷擴大、基因組學的日益普及、藥物發現和開發日益受到重視，以及與傳統技術相比效率的提高，預計將成為全球第三代定序市場成長的主要驅動力。

例如，隨著慢性病負擔的加重，基於第三代定序技術的設備的使用和需求也迅速成長。 TGS技術可用於基因表現研究，因為它有助於闡明慢性病的分子機制。根據世界衛生組織（WHO）2023年9月發布的報告，非傳染性疾病（NCDs）每年奪走4,100萬人的生命，佔全球所有死亡人數的74%。非傳染性疾病死亡的主要原因是心血管疾病，每年造成1,790萬人死亡，其次是癌症（930萬人）、慢性呼吸道疾病（410萬人）和糖尿病（200萬人）。

此外，根據美國疾病管制與預防中心（CDC）的數據，心臟病、癌症和糖尿病等慢性疾病是美國死亡和殘疾的主要原因。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於公司亮點、產品系列、關鍵特性、財務表現和策略等參數，分析了全球第三代定序市場的主要參與者。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球第三代定序市場報告的目標受眾是業內各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球第三代定序市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 1069.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	21.30%	2033 Value Projection:	USD 4,131 Mn

Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the 'gold-standard' technology for cDNA sequencing.

Market Dynamics

Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.

For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. TGS technologies can be utilized in studying gene expression of chronic diseases as it help in understanding their molecular mechanisms. According to the World Health Organization (WHO), September 2023 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include PacBio , Oxford Nanopore Technologies, Ltd., BGI Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC Biotech AG, and Phase Genomics, Inc., among others
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.

Market Segmentation

By Technology (Revenue, USD Mn, 2021 - 2033)
Single-Molecule Real-Time (SMRT) Sequencing
Nanopore Sequencing
Synthetic long-read sequencing
By Component (Revenue, USD Mn, 2021 - 2033)
Products
Services
By (Revenue, USD Mn, 2021 - 2033) Application
Genome Sequencing
Epigenetics
Transcriptomics
Metagenomics
Others
By End-user (Revenue, USD Mn, 2021 - 2033)
Biopharmaceutical companies
Hospitals and clinics
Contract research organizations (CROs)
Others (Academic and research institutes)
By Geography (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
PacBio
Oxford Nanopore Technologies, Ltd.
BGI Genomics Co., Ltd.
F.Hoffmann-La Roche AG
Illumina, Inc.
Thermo Fisher Scientific Inc.
QIAGEN N.V.
Agilent Technologies, Inc.
GenapSys Inc.
Loop Genomics
Nabsys, Inc.
Genia Technologies, Inc.
Stratos Genomics, Inc.
GATC Biotech AG
Phase Genomics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Third Generation Sequencing, By Type of Technology
- Market Third Generation Sequencing, By Component
- Market Third Generation Sequencing, By Application
- Market Third Generation Sequencing, By End User
- Market Third Generation Sequencing, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing Demand for Precision Medicine
- High Cost & Technical Challenges
- Increasing Adoption of TGS Platforms
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Third Generation Sequencing Market, By Technology, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Single-molecule real-time (SMRT) sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Nanopore Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Synthetic long-read sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

5. Third Generation Sequencing Market, By Component, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
  - Instruments
  - Reagents and consumables
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

6. Third Generation Sequencing Market, By Application, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Genome Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Epigenetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Transcriptomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Metagenomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

7. Third Generation Sequencing Market, By End User, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Contract research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)

8. Third Generation Sequencing Market, By Geography, 2026 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

PacBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Nanopore Technologies, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenapSys Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Loop Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nabsys, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genia Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stratos Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GATC Biotech AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Phase Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views